Browse > Article

In Vitro Selection of Cancer-Specific RNA Aptamers  

Lee Young-Ju (Department of Molecular Biology, Institute of Nanosensor and Biotechnology, Dankook University)
Lee Seong-Wook (Department of Molecular Biology, Institute of Nanosensor and Biotechnology, Dankook University)
Publication Information
Journal of Microbiology and Biotechnology / v.16, no.7, 2006 , pp. 1149-1153 More about this Journal
Abstract
In this study, nuclease-resistant RNA aptamers that are specific for Jurkat T leukemia cells were selected by a subtractive systemic evolution of ligands by exponential enrichment (SELEX) method. A randomized nuclease-resistant RNA library was incubated with normal peripheral blood mononuclear cells (PBMC) in each round to preclude RNAs that recognize the common cellular components on the surface of normal and cancer cells. The precluded RNAs were used for the selection of Jurkat T cell-specific aptamers, and the specific RNAs were then gradually enriched from start to the following selections. After 16 rounds of the subtractive SELEX, the selected aptamers were found to preferentially bind to Jurkat T cells, but not to the normal PBMC, evidenced by fluorescence-activated cell sorting analysis. Thus, the subtractive SELEX can be used to identify ligands to cancer-specific biological markers without prior knowledge of the nature of markers. The aptamers could be applied to specific cell sorting, tumor therapy, and diagnosis, and moreover, to find cancer cell-specific markers.
Keywords
Cancer; FACS; Jurkat T cell leukemia; RNA aptamers; SELEX;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
Times Cited By Web Of Science : 7  (Related Records In Web of Science)
연도 인용수 순위
1 Bae, S. J., J. H. Oum, S. Sharma, J. Park, and S. W. Lee. 2002. In vitro selection of specific RNA inhibitors of NFATc. Biochem. Biophys. Res. Commun. 298: 486-492   DOI   ScienceOn
2 Burgstaller, P., A. Girod, and M. Blind. 2002. Aptamers as tools for target prioritization and lead identification. Drug Discov. Today 7: 1221-1228   DOI   ScienceOn
3 Pagratis, N. C., C. Bell, Y. F. Chang, S. Jennings, T. Fitzwater, D. Jellinek, and C. Dang. 1997. Potent 2'-amino, and 2'-fluoro-2'deoxyribonucleotide RNA inhibitors of keratinocyte growth factor. Nature Biotechnol. 15: 68-73   DOI   ScienceOn
4 Wang, C., M. Zhang, G. Yang, D. Zhang, H. Ding, H. Wang, M. Fan, B. Shen, and N. Shap. 2003. Single-stranded DNA aptamers that bind differentiated but not parental cells: Subtractive systemic evolution of ligands by exponential enrichment. J. Biotechnol. 102: 15-22   DOI   ScienceOn
5 Klubmann, S., A. Nolte, A. Bald, V. A. Erdmann, and J. P. Furste. 1996. Mirror-image RNA that binds D-adenosine. Nat. Biotechnol.14: 1112-1115   DOI   ScienceOn
6 Daniels, D. A., H. Chen, B. J. Ricke, K. M. Swiderek, and L. Gold. 2003. A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment. Proc. Natl. Acad. Sci. USA 100: 15416-15421
7 Ellington, A. D. and J. W. Szostak. 1990. In vitro selection of RNA molecules that bind specific ligands. Nature 346: 818-822   DOI   ScienceOn
8 Lim, H., M. K. Kim, Y. H. Cho, J. M. Kim, Y. Lim, and C. H. Lee. 2004. Inhibition of cell cycle progression and induction of apoptosis in HeLa cells by HY558-1, novel CDK inhibitor isolated from Penicillium minioluteum F558. J. Microbiol. Biotechnol. 14: 978-984
9 Seo, H. S. and S. W. Lee. 2000. In vitro selection of the 2'-fluoro-2'-deoxyribonucleotide decoy RNA inhibitor of myasthenic autoantibodies. J. Microbiol. Biotechnol. 10: 707-713
10 Gold, L., P. Allen, J. Binkley, D. Brown, D. Schneider, S. R. Eddy, C. Tuerk, L. Green, S. Macdougal, and D. Tasset. 1993. RNA: The shape of things to come, pp. 497-510. In R. F. Gestelend and J. F. Atkins (eds.). The RNA World. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., U.S.A
11 Park, K. S., Y. J. Bae, E. J. Jung, and S. J. Kang. 2005. RTPCR-based detection of six garlic viruses and their phylogenetic relationships. J. Microbiol. Biotechnol. 15: 1110-1114   과학기술학회마을
12 Lee, S. W. and B. Sullenger. 1997. Isolation of a nucleaseresistant decoy RNA that can protect human acetylcholine receptors from myasthenic antibodies. Nat. Biotechnol. 15: 41-45   DOI   ScienceOn
13 Lauhon, C. T. and J. W. Szostak. 1995. RNA aptamers that bind flavin and nicotinamide redox cofactors. J. Am. Chem. Soc. 117: 1246-1257   DOI   ScienceOn
14 Kim, H., S. J. Kim, S. N. Park, and J. W. Oh. 2004. Antiviral effect of amphotericin B on Japanese encephalitis virus replication. J. Microbiol. Biotechnol. 14: 121-127
15 Rusconi, C. P., J. D. Roberts, G. A. Pitoc, S. M. Nimjee, R. R. White, G. Jr. Quick, E. Scardino, W. P. Fay, and B. A. Sullenger. 2004. Antidote-mediated control of an anticoagulant aptamer in vivo. Nat. Biotechnol. 22: 1423-1428   DOI   ScienceOn
16 Sullenger, B. A. and E. Gilboa. 2002. Emerging clinical applications of RNA. Nature 418: 252-258   DOI   ScienceOn
17 Morris, K. N., K. B. Jensen, C. M. Julin, M. Well, and L. Gold. 1998. High affinity ligands from in vitro selection: Complex targets. Proc. Natl. Acad. Sci. USA 95: 2902-2907
18 Lee, S. W. and B. Sullenger. 1996. Isolation of a nuclease resistant decoy RNA that selectively blocks autoantibody binding to insulin receptors on human lymphocytes. J. Exp. Med.194: 315-324
19 Tuerk, C. and L. Gold. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 505-510   DOI
20 Jung, H. S. and S. W. Lee. 2005. Re-engineering of carcinoembryonic antigen RNA with the group I intron of Tetrahymena thermophila by targeted trans-splicing. J. Microbiol. Biotechnol. 15: 1408-1413   과학기술학회마을
21 Hwang, B. and S. W. Lee. 2005. Analysis of in vivo interaction of HCV NS3 protein and specific RNA aptamer with yeast three-hybrid system. J. Microbiol. Biotechnol. 15: 660-664   과학기술학회마을
22 Strausberg, R. L., A. J. Simpson, L. J. Old, and G. J. Riggins. 2004. Oncogenomics and the development of new cancer therapies. Nature 429: 469-474   DOI   ScienceOn
23 Rosemeyer, V., A. Laubrock, and R. Seibl. 1995. Nonradioactive 3'-end-Iabeling of RNA molecules of different lengths by terminal deoxynucleotidyltransferase. Anal. Biochem. 224: 446-449   DOI   ScienceOn
24 Lupold, S. E., B. Hicke, Y. Lin, and D. S. Coffey. 2002. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res. 62: 4029-4033
25 Hwang, B., K. Han, and S. W. Lee. 2003. Prevention of passively transferred experimental autoimmune myasthenia gravis by an in vitro selected RNA aptamer. FEBS Lett. 548: 85-89   DOI   ScienceOn